825
Participants
Start Date
June 30, 2011
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Placebo
Placebo matching BI 10773 low dose
BI 10773
BI 10773 high dose once daily
Placebo
Placebo matching BI 10773 low dose
BI 10773
BI 10773 low dose once daily
Placebo
Placebo matching BI 10773 high dose
Placebo
Placebo matching BI 10773 high dose
1245.48.10024 Boehringer Ingelheim Investigational Site, Huntsville
1245.48.10002 Boehringer Ingelheim Investigational Site, Phoenix
1245.48.10014 Boehringer Ingelheim Investigational Site, Lincoln
1245.48.10030 Boehringer Ingelheim Investigational Site, Long Beach
1245.48.10033 Boehringer Ingelheim Investigational Site, Long Beach
1245.48.10027 Boehringer Ingelheim Investigational Site, Los Angeles
1245.48.10041 Boehringer Ingelheim Investigational Site, Tustin
1245.48.10039 Boehringer Ingelheim Investigational Site, West Hills
1245.48.10008 Boehringer Ingelheim Investigational Site, Davie
1245.48.10025 Boehringer Ingelheim Investigational Site, Edgewater
1245.48.10001 Boehringer Ingelheim Investigational Site, Jacksonville
1245.48.10016 Boehringer Ingelheim Investigational Site, Miami
1245.48.10035 Boehringer Ingelheim Investigational Site, Palm Harbor
1245.48.10018 Boehringer Ingelheim Investigational Site, Pensacola
1245.48.10032 Boehringer Ingelheim Investigational Site, Pinellas Park
1245.48.10012 Boehringer Ingelheim Investigational Site, Marietta
1245.48.10011 Boehringer Ingelheim Investigational Site, Addison
1245.48.10019 Boehringer Ingelheim Investigational Site, Arlington Heights
1245.48.10022 Boehringer Ingelheim Investigational Site, Chicago
1245.48.10017 Boehringer Ingelheim Investigational Site, Wichita
1245.48.10010 Boehringer Ingelheim Investigational Site, Albuquerque
1245.48.10036 Boehringer Ingelheim Investigational Site, Charlotte
1245.48.10005 Boehringer Ingelheim Investigational Site, Akron
1245.48.10004 Boehringer Ingelheim Investigational Site, Kettering
1245.48.10013 Boehringer Ingelheim Investigational Site, Erie
1245.48.10020 Boehringer Ingelheim Investigational Site, Pittsburgh
1245.48.10029 Boehringer Ingelheim Investigational Site, Knoxville
1245.48.10015 Boehringer Ingelheim Investigational Site, Memphis
1245.48.10034 Boehringer Ingelheim Investigational Site, Dallas
1245.48.10007 Boehringer Ingelheim Investigational Site, Houston
1245.48.10009 Boehringer Ingelheim Investigational Site, Houston
1245.48.10042 Boehringer Ingelheim Investigational Site, Houston
1245.48.10026 Boehringer Ingelheim Investigational Site, San Antonio
1245.48.10003 Boehringer Ingelheim Investigational Site, Orem
1245.48.10023 Boehringer Ingelheim Investigational Site, Port Orchard
1245.48.20002 Boehringer Ingelheim Investigational Site, Winnipeg
1245.48.20001 Boehringer Ingelheim Investigational Site, Halifax
1245.48.20004 Boehringer Ingelheim Investigational Site, Brampton
1245.48.20006 Boehringer Ingelheim Investigational Site, Etobicoke
1245.48.20007 Boehringer Ingelheim Investigational Site, Oakville
1245.48.20005 Boehringer Ingelheim Investigational Site, Thornhill
1245.48.20003 Boehringer Ingelheim Investigational Site, Toronto
1245.48.42003 Boehringer Ingelheim Investigational Site, Benešov
1245.48.42005 Boehringer Ingelheim Investigational Site, Brno
1245.48.42002 Boehringer Ingelheim Investigational Site, Mladá Boleslav
1245.48.42006 Boehringer Ingelheim Investigational Site, Neratovice
1245.48.42008 Boehringer Ingelheim Investigational Site, Olomouc
1245.48.42004 Boehringer Ingelheim Investigational Site, Opočno
1245.48.42007 Boehringer Ingelheim Investigational Site, Příbram
1245.48.42001 Boehringer Ingelheim Investigational Site, Slaný
1245.48.45006 Boehringer Ingelheim Investigational Site, Aalborg
1245.48.45009 Boehringer Ingelheim Investigational Site, Aarhus C
1245.48.45002 Boehringer Ingelheim Investigational Site, Elsinore
1245.48.45008 Boehringer Ingelheim Investigational Site, Hellerup
1245.48.45010 Boehringer Ingelheim Investigational Site, Hillerød
1245.48.45003 Boehringer Ingelheim Investigational Site, København NV
1245.48.45001 Boehringer Ingelheim Investigational Site, Rødovre Municipality
1245.48.45004 Boehringer Ingelheim Investigational Site, Rødovre Municipality
1245.48.45005 Boehringer Ingelheim Investigational Site, Vaerløse
1245.48.45007 Boehringer Ingelheim Investigational Site, Vojens
1245.48.37203 Boehringer Ingelheim Investigational Site, Pärnu
1245.48.37201 Boehringer Ingelheim Investigational Site, Tallinn
1245.48.37202 Boehringer Ingelheim Investigational Site, Tallinn
1245.48.37204 Boehringer Ingelheim Investigational Site, Tallinn
1245.48.35802 Boehringer Ingelheim Investigational Site, Helsinki
1245.48.35805 Boehringer Ingelheim Investigational Site, Joensuu
1245.48.35806 Boehringer Ingelheim Investigational Site, Kouvola
1245.48.35803 Boehringer Ingelheim Investigational Site, Oulu
1245.48.35804 Boehringer Ingelheim Investigational Site, Pori
1245.48.35801 Boehringer Ingelheim Investigational Site, Turku
1245.48.35807 Boehringer Ingelheim Investigational Site, Turku
1245.48.33004 Boehringer Ingelheim Investigational Site, Angers
1245.48.33008 Boehringer Ingelheim Investigational Site, Bourges
1245.48.33005 Boehringer Ingelheim Investigational Site, Mont-de-Marsan
1245.48.33001 Boehringer Ingelheim Investigational Site, Nantes
1245.48.33006 Boehringer Ingelheim Investigational Site, Orthez
1245.48.33003 Boehringer Ingelheim Investigational Site, Tiercé
1245.48.33007 Boehringer Ingelheim Investigational Site, Tours
1245.48.49001 Boehringer Ingelheim Investigational Site, Berlin
1245.48.49008 Boehringer Ingelheim Investigational Site, Berlin
1245.48.49003 Boehringer Ingelheim Investigational Site, Dresden
1245.48.49004 Boehringer Ingelheim Investigational Site, Hanover
1245.48.49005 Boehringer Ingelheim Investigational Site, Lüneburg
1245.48.49002 Boehringer Ingelheim Investigational Site, Mainz
1245.48.49010 Boehringer Ingelheim Investigational Site, Nuremberg
1245.48.49009 Boehringer Ingelheim Investigational Site, Pirna
1245.48.49007 Boehringer Ingelheim Investigational Site, Schkeuditz
1245.48.49006 Boehringer Ingelheim Investigational Site, Teuchern
1245.48.96003 Boehringer Ingelheim Investigational Site, Baabda
1245.48.96001 Boehringer Ingelheim Investigational Site, Beirut
1245.48.96002 Boehringer Ingelheim Investigational Site, Lebanon
1245.48.31011 Boehringer Ingelheim Investigational Site, Breda
1245.48.31012 Boehringer Ingelheim Investigational Site, Eindhoven
1245.48.31009 Boehringer Ingelheim Investigational Site, Etten-Leur
1245.48.31014 Boehringer Ingelheim Investigational Site, Groningen
1245.48.31013 Boehringer Ingelheim Investigational Site, Leiderdorp
1245.48.31003 Boehringer Ingelheim Investigational Site, Oude Pekela
1245.48.31016 Boehringer Ingelheim Investigational Site, Rotterdam
1245.48.31006 Boehringer Ingelheim Investigational Site, Soerendonk
1245.48.31008 Boehringer Ingelheim Investigational Site, Spijkenisse
1245.48.31002 Boehringer Ingelheim Investigational Site, Swifterbant
1245.48.31015 Boehringer Ingelheim Investigational Site, Velp
1245.48.31010 Boehringer Ingelheim Investigational Site, Woerden
1245.48.31019 Boehringer Ingelheim Investigational Site, Zijndrecht
1245.48.31017 Boehringer Ingelheim Investigational Site, Zoetermeer
1245.48.47009 Boehringer Ingelheim Investigational Site, Ålesund
1245.48.47008 Boehringer Ingelheim Investigational Site, Elverum
1245.48.47007 Boehringer Ingelheim Investigational Site, Hamar
1245.48.47002 Boehringer Ingelheim Investigational Site, Kløfta
1245.48.47001 Boehringer Ingelheim Investigational Site, Oslo
1245.48.47003 Boehringer Ingelheim Investigational Site, Oslo
1245.48.47004 Boehringer Ingelheim Investigational Site, Oslo
1245.48.47005 Boehringer Ingelheim Investigational Site, Oslo
1245.48.47006 Boehringer Ingelheim Investigational Site, Sørumsand
1245.48.46002 Boehringer Ingelheim Investigational Site, Härnösand
1245.48.46004 Boehringer Ingelheim Investigational Site, Järfälla
1245.48.46003 Boehringer Ingelheim Investigational Site, Lund
1245.48.46007 Boehringer Ingelheim Investigational Site, Malmo
1245.48.46006 Boehringer Ingelheim Investigational Site, Skene
1245.48.46001 Boehringer Ingelheim Investigational Site, Stockholm
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY